Talaris Therapeutics, Inc.

NASDAQ:TALS

2.72 (USD) • At close October 19, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -22.97-28.96-20.1770-7.015-14.738-22.497-18.528-19.011-18.096-18.259-14.241-12.941-11.352-9.299-6.779-6.417-4.663-4.848
Depreciation & Amortization 0.012-0.8610.01000.2610.6390.5530.570.5510.4880.1880.1670.1330.1350.1250.1290.1010.092
Deferred Income Tax 015.283000-15.28300000000.1090.1930.226000
Stock Based Compensation 2.2731.763.0680.41601.1743.6593.0723.0412.8462.1970.9941.0530.8960.8350.5930.1860.120.123
Change In Working Capital 00.981.84300-0.831-0.1492.0252.267-2.486-0.7093.2131.516-1.143-1.2710.1750.9991.001-0.561
Accounts Receivables 0000000000000000000
Change In Inventory 0000000000000000000
Change In Accounts Payables -1.3493.264-0.33300-0.413-0.4141.879-0.131-0.8390.7551.113-0.2870.4960.0010.006-0.1090.0650.138
Other Working Capital 00.0040.48600-0.4180.4140.1462.398-1.647-1.4642.11.803-1.639-1.2720.1691.1080.936-0.699
Other Non Cash Items 0-26.869-8.18807.01514.7381.446-0.992-0.294-0.0950.0030.0160.0760.4840.5530.2360.277-0.052-0.049
Operating Cash Flow -21.679-38.667-23.4440-7.015-14.679-16.902-13.87-13.427-17.28-16.28-9.83-10.129-10.982-9.047-5.65-4.826-3.493-5.243
Investing Activities:
Investments In Property Plant And Equipment -0.0090.532000-0.221-0.32-0.269-0.341-1.092-1.341-1.189-0.726-0.335-0.187-0.249-0.342-0.346-0.349
Acquisitions Net 00.037000-0.009-0.028-0.009-0.0070000000000
Purchases Of Investments -85.164-291.506-88.04500-49.36-25.27-50.991-52.605-48.001-39.982-65.09-35.945-140.547-34.297-107.113-28.02-3.998-19.106
Sales Maturities Of Investments 111.11460.3476.350058.55360.27259.2569.02161.756738.36540.7535.814315.3147.910
Other Investing Activites 0-0.0370000.0090.0280.0090.007000000-0.001000
Investing Cash Flow 25.941-230.634-11.695008.91927.419.0126.30419.92820.4270.7211.694-100.1321.33-104.363-13.0483.566-19.455
Financing Activities:
Debt Repayment 0000000000000000000
Common Stock Issued -0.007161.35200000000000000000
Common Stock Repurchased 00000-00000000000000
Dividends Paid 0000000000000000000
Other Financing Activities 0.569-0.187-0.001000.1370.0460.060.0730.0790.030.412-0.551137.5220.017-0.524131.6230.0240
Financing Cash Flow 0.562161.165-0.001000.1370.04600000-0.0010.1380-0.524131.6230.0240
Other Information:
Effect Of Forex Changes On Cash 09.115000-9.1150000000000000
Net Change In Cash 4.82437.748-34.9130-7.015-5.62310.554-4.798-7.052.7274.177-8.697-8.98626.408-7.7-110.537113.7490.097-24.698
Cash At End Of Period 35.55730.73335.2350-7.01518.60124.22413.6718.46825.51822.79118.61427.31136.2979.88917.589128.12614.37714.28